Cargando…
Alteration of microRNA expressions in the pons and medulla in rats after 3,3′-iminodipropionitrile administration
Although 3,3′-iminodipropionitrile (IDPN) is widely used as a neurotoxicant to cause axonopathy due to accumulation of neurofilaments in several rodent models, its mechanism of neurotoxicity has not been fully understood. In particular, no information regarding microRNA (miRNA) alteration associated...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Japanese Society of Toxicologic Pathology
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5097965/ https://www.ncbi.nlm.nih.gov/pubmed/27821907 http://dx.doi.org/10.1293/tox.2016-0019 |
_version_ | 1782465693336207360 |
---|---|
author | Ogata, Keiko Kushida, Masahiko Miyata, Kaori Sumida, Kayo Takeda, Shuji Izawa, Takeshi Kuwamura, Mitsuru Yamate, Jyoji |
author_facet | Ogata, Keiko Kushida, Masahiko Miyata, Kaori Sumida, Kayo Takeda, Shuji Izawa, Takeshi Kuwamura, Mitsuru Yamate, Jyoji |
author_sort | Ogata, Keiko |
collection | PubMed |
description | Although 3,3′-iminodipropionitrile (IDPN) is widely used as a neurotoxicant to cause axonopathy due to accumulation of neurofilaments in several rodent models, its mechanism of neurotoxicity has not been fully understood. In particular, no information regarding microRNA (miRNA) alteration associated with IDPN is available. This study was conducted to reveal miRNA alteration related to IDPN-induced neurotoxicity. Rats were administered IDPN (20, 50, or 125 mg/kg/day) orally for 3, 7, and 14 days. Histopathological features were investigated using immunohistochemistry for neurofilaments and glial cells, and miRNA alterations were analyzed by microarray and reverse transcription polymerase chain reaction. Nervous symptoms such as ataxic gait and head bobbing were observed from Day 9 at 125 mg/kg. Axonal swelling due to accumulation of neurofilaments was observed especially in the pons, medulla, and spinal cord on Day 7 at 125 mg/kg and on Day 14 at 50 and 125 mg/kg. Furthermore, significant upregulation of miR-547* was observed in the pons and medulla in treated animals only on Day 14 at 125 mg/kg. This is the first report indicating that miR-547* is associated with IDPN-induced neurotoxicity, especially in an advanced stage of axonopathy. |
format | Online Article Text |
id | pubmed-5097965 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Japanese Society of Toxicologic Pathology |
record_format | MEDLINE/PubMed |
spelling | pubmed-50979652016-11-07 Alteration of microRNA expressions in the pons and medulla in rats after 3,3′-iminodipropionitrile administration Ogata, Keiko Kushida, Masahiko Miyata, Kaori Sumida, Kayo Takeda, Shuji Izawa, Takeshi Kuwamura, Mitsuru Yamate, Jyoji J Toxicol Pathol Original Article Although 3,3′-iminodipropionitrile (IDPN) is widely used as a neurotoxicant to cause axonopathy due to accumulation of neurofilaments in several rodent models, its mechanism of neurotoxicity has not been fully understood. In particular, no information regarding microRNA (miRNA) alteration associated with IDPN is available. This study was conducted to reveal miRNA alteration related to IDPN-induced neurotoxicity. Rats were administered IDPN (20, 50, or 125 mg/kg/day) orally for 3, 7, and 14 days. Histopathological features were investigated using immunohistochemistry for neurofilaments and glial cells, and miRNA alterations were analyzed by microarray and reverse transcription polymerase chain reaction. Nervous symptoms such as ataxic gait and head bobbing were observed from Day 9 at 125 mg/kg. Axonal swelling due to accumulation of neurofilaments was observed especially in the pons, medulla, and spinal cord on Day 7 at 125 mg/kg and on Day 14 at 50 and 125 mg/kg. Furthermore, significant upregulation of miR-547* was observed in the pons and medulla in treated animals only on Day 14 at 125 mg/kg. This is the first report indicating that miR-547* is associated with IDPN-induced neurotoxicity, especially in an advanced stage of axonopathy. Japanese Society of Toxicologic Pathology 2016-06-03 2016-10 /pmc/articles/PMC5097965/ /pubmed/27821907 http://dx.doi.org/10.1293/tox.2016-0019 Text en ©2016 The Japanese Society of Toxicologic Pathology http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License. |
spellingShingle | Original Article Ogata, Keiko Kushida, Masahiko Miyata, Kaori Sumida, Kayo Takeda, Shuji Izawa, Takeshi Kuwamura, Mitsuru Yamate, Jyoji Alteration of microRNA expressions in the pons and medulla in rats after 3,3′-iminodipropionitrile administration |
title | Alteration of microRNA expressions in the pons and medulla in rats after 3,3′-iminodipropionitrile administration |
title_full | Alteration of microRNA expressions in the pons and medulla in rats after 3,3′-iminodipropionitrile administration |
title_fullStr | Alteration of microRNA expressions in the pons and medulla in rats after 3,3′-iminodipropionitrile administration |
title_full_unstemmed | Alteration of microRNA expressions in the pons and medulla in rats after 3,3′-iminodipropionitrile administration |
title_short | Alteration of microRNA expressions in the pons and medulla in rats after 3,3′-iminodipropionitrile administration |
title_sort | alteration of microrna expressions in the pons and medulla in rats after 3,3′-iminodipropionitrile administration |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5097965/ https://www.ncbi.nlm.nih.gov/pubmed/27821907 http://dx.doi.org/10.1293/tox.2016-0019 |
work_keys_str_mv | AT ogatakeiko alterationofmicrornaexpressionsintheponsandmedullainratsafter33iminodipropionitrileadministration AT kushidamasahiko alterationofmicrornaexpressionsintheponsandmedullainratsafter33iminodipropionitrileadministration AT miyatakaori alterationofmicrornaexpressionsintheponsandmedullainratsafter33iminodipropionitrileadministration AT sumidakayo alterationofmicrornaexpressionsintheponsandmedullainratsafter33iminodipropionitrileadministration AT takedashuji alterationofmicrornaexpressionsintheponsandmedullainratsafter33iminodipropionitrileadministration AT izawatakeshi alterationofmicrornaexpressionsintheponsandmedullainratsafter33iminodipropionitrileadministration AT kuwamuramitsuru alterationofmicrornaexpressionsintheponsandmedullainratsafter33iminodipropionitrileadministration AT yamatejyoji alterationofmicrornaexpressionsintheponsandmedullainratsafter33iminodipropionitrileadministration |